BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10071467)

  • 1. Bioactivity of pseudowollastonite in human saliva.
    De Aza PN; Luklinska ZB; Anseau MR; Guitian F; De Aza S
    J Dent; 1999 Feb; 27(2):107-13. PubMed ID: 10071467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivity of diopside ceramic in human parotid saliva.
    De Aza PN; Luklinska ZB; Anseau M
    J Biomed Mater Res B Appl Biomater; 2005 Apr; 73(1):54-60. PubMed ID: 15739173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological studies of pseudowollastonite for biomedical application.
    de Aza PN; Luklinska ZB; Anseau M; Guitian F; de Aza S
    J Microsc; 1996 Apr; 182(Pt 1):24-31. PubMed ID: 8632444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and structural study of pseudowollastonite implants in bone.
    De Aza PN; Luklinska ZB; Martinez A; Anseau MR; Guitian F; De Aza S
    J Microsc; 2000 Jan; 197(Pt 1):60-7. PubMed ID: 10620149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic silicate active site and stereochemical match for apatite nucleation on pseudowollastonite bioceramic-bone interfaces.
    Sahai N; Anseau M
    Biomaterials; 2005 Oct; 26(29):5763-70. PubMed ID: 15949543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro bioactivity of laser ablation pseudowollastonite coating.
    De Aza PN; Fernández-Pradas JM; Serra P
    Biomaterials; 2004 May; 25(11):1983-90. PubMed ID: 14741612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricalcium silicate induced mineralization for occlusion of dentinal tubules.
    Dong Z; Chang J; Deng Y; Joiner A
    Aust Dent J; 2011 Jun; 56(2):175-80. PubMed ID: 21623810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hydroxyapatite growth by casein, a potential salivary phosphoprotein homologue.
    Romero MJ; Nakashima S; Nikaido T; Ichinose S; Sadr A; Tagami J
    Eur J Oral Sci; 2015 Aug; 123(4):288-96. PubMed ID: 26083784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical characterization of the surface layers formed on dentin following treatment with a fluoridated toothpaste containing NovaMin.
    Earl JS; Topping N; Elle J; Langford RM; Greenspan DC
    J Clin Dent; 2011; 22(3):68-73. PubMed ID: 21905400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission electron microscopy of the interface between bone and pseudowollastonite implant.
    De Aza PN; Luklinska ZB; Anseau MR; Guitian F; De Aza S
    J Microsc; 2001 Jan; 201(Pt 1):33-43. PubMed ID: 11136437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical characterization of dentin surface following treatment with NovaMin technology.
    Earl JS; Leary RK; Muller KH; Langford RM; Greenspan DC
    J Clin Dent; 2011; 22(3):62-7. PubMed ID: 21905399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulsed laser deposition of pseudowollastonite coatings.
    Fernández-Pradas JM; Serra P; Morenza JL; De Aza PN
    Biomaterials; 2002 May; 23(9):2057-61. PubMed ID: 11996047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomineralization ability and interaction of mineral trioxide aggregate and white portland cement with dentin in a phosphate-containing fluid.
    Reyes-Carmona JF; Felippe MS; Felippe WT
    J Endod; 2009 May; 35(5):731-6. PubMed ID: 19410094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of a wollastonite-tricalcium phosphate Bioeutectic ceramic in human parotid saliva.
    De Aza PN; Luklinska ZB; Anseau MR; Hector M; Guitián F; De Aza S
    Biomaterials; 2000 Sep; 21(17):1735-41. PubMed ID: 10905455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxyapatite/SiO(2)-CaO-P(2)O(5) glass materials: in vitro bioactivity and biocompatibility.
    Padilla S; Román J; Sánchez-Salcedo S; Vallet-Regí M
    Acta Biomater; 2006 May; 2(3):331-42. PubMed ID: 16701892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interfacial characteristics of Biodentine and MTA with dentine in simulated body fluid.
    Kim JR; Nosrat A; Fouad AF
    J Dent; 2015 Feb; 43(2):241-7. PubMed ID: 25478890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro hydroxyapatite forming ability and dissolution of tobermorite nanofibers.
    Lin K; Chang J; Cheng R
    Acta Biomater; 2007 Mar; 3(2):271-6. PubMed ID: 17234465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of plasma-sprayed wollastonite coating in simulated body fluid.
    Liu X; Ding C
    J Biomed Mater Res; 2002 Feb; 59(2):259-64. PubMed ID: 11745561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphate removal and recovery through crystallization of hydroxyapatite using xonotlite as seed crystal.
    Chen X; Kong H; Wu D; Wang X; Lin Y
    J Environ Sci (China); 2009; 21(5):575-80. PubMed ID: 20108657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of natural and synthetic wollastonite as source for bioceramics preparation.
    Carrodeguas RG; De Aza AH; De Aza PN; Baudín C; Jiménez J; López-Bravo A; Pena P; De Aza S
    J Biomed Mater Res A; 2007 Nov; 83(2):484-95. PubMed ID: 17503534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.